Healthcare burden of recurrent Clostridioides difficile infection in Japan: A retrospective database study
Open Access
- 1 November 2018
- journal article
- research article
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 24 (11) , 892-901
Abstract
No abstract availableKeywords
Funding Information
- Merck Sharp and Dohme K.K.
- Toyama Chemical Co., Ltd.
- Taisho Toyama Pharmaceutical Co., Ltd.
This publication has 28 references indexed in Scilit:
- Treatment of First Recurrence of Clostridium difficile Infection: Fidaxomicin Versus VancomycinClinical Infectious Diseases, 2012
- Consequences of Clostridium difficile infection: understanding the healthcare burdenClinical Microbiology and Infection, 2012
- Automated Surveillance of Clostridium difficile Infections Using BioSenseInfection Control & Hospital Epidemiology, 2011
- Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)Infection Control & Hospital Epidemiology, 2010
- Clostridium difficile infection: new developments in epidemiology and pathogenesisNature Reviews Microbiology, 2009
- Health Care–AssociatedClostridium difficileInfection in Adults Admitted to Acute Care Hospitals in Canada: A Canadian Nosocomial Infection Surveillance Program StudyClinical Infectious Diseases, 2009
- Management and Outcomes of a First Recurrence of Clostridium difficile-Associated Disease in Quebec, CanadaClinical Infectious Diseases, 2006
- An Epidemic, Toxin Gene–Variant Strain ofClostridium difficileNew England Journal of Medicine, 2005
- Recurrent Clostridium Difficile Disease: Epidemiology and Clinical CharacteristicsInfection Control & Hospital Epidemiology, 1999
- Recurrent Clostridium difficile Diarrhea: Characteristics of and Risk Factors for Patients Enrolled in a Prospective, Randomized, Double-Blinded TrialClinical Infectious Diseases, 1997